Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04832854
Brief Title: A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

First Submitted : April 2, 2021
First Submitted that Met QC Criteria : April 2, 2021
First Posted : April 6, 2021

Last Update Submitted that Met QC Criteria : November 3, 2021
Last Update Posted : November 4, 2021